Shawn Cross, CFO of Pacira BioSciences ($PCRX), sold shares on the open market three times over the past year, totaling about $893,000. His most recent sale occurred on December 10, 2025. These sales rank 5,195th among 11,678 insiders in our database, where the average is $8.6 million across roughly 6.4 transactions per insider. Cross made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 23, 2026 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | M | Common Stock | 12941 | $16.45 | 118,282.0000 | 45,729,000 | 12.28% | 0.03% |
| April 23, 2026 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | M | Stock Option (Right to Buy) | 12941 | $0.00 | 150,000.0000 | 45,729,000 | 7.94% | 0.03% |
| April 23, 2026 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | S | Common Stock | 12941 | $25.16 | 105,341.0000 | 45,729,000 | 10.94% | 0.03% |
| April 20, 2026 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | M | Common Stock | 7714 | $16.45 | 113,055.0000 | 45,729,000 | 7.32% | 0.02% |
| April 20, 2026 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | S | Common Stock | 7714 | $25.14 | 105,341.0000 | 45,729,000 | 6.82% | 0.02% |
| April 21, 2026 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | M | Common Stock | 2845 | $16.45 | 108,186.0000 | 45,729,000 | 2.70% | 0.01% |
| April 21, 2026 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | S | Common Stock | 2845 | $25.01 | 105,341.0000 | 45,729,000 | 2.63% | 0.01% |
| April 22, 2026 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | M | Common Stock | 1500 | $16.45 | 106,841.0000 | 45,729,000 | 1.42% | 0.00% |
| April 22, 2026 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | S | Common Stock | 1500 | $25.01 | 105,341.0000 | 45,729,000 | 1.40% | 0.00% |
| April 20, 2026 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | M | Stock Option (Right to Buy) | 7714 | $0.00 | 167,286.0000 | 45,729,000 | 4.41% | 0.02% |
| April 21, 2026 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | M | Stock Option (Right to Buy) | 2845 | $0.00 | 164,441.0000 | 45,729,000 | 1.70% | 0.01% |
| April 22, 2026 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | M | Stock Option (Right to Buy) | 1500 | $0.00 | 162,941.0000 | 45,729,000 | 0.91% | 0.00% |
| Feb. 11, 2026 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | A | Common Stock | 49091 | $0.00 | 105,341.0000 | 45,729,000 | 87.27% | 0.11% |
| Dec. 9, 2025 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | M | Stock Option (Right to Buy) | 15896 | $0.00 | 184,104.0000 | 45,729,000 | 7.95% | 0.03% |
| Dec. 10, 2025 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | M | Stock Option (Right to Buy) | 9104 | $0.00 | 175,000.0000 | 45,729,000 | 4.95% | 0.02% |
| Dec. 9, 2025 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | M | Common Stock | 15896 | $16.45 | 72,146.0000 | 45,729,000 | 28.26% | 0.03% |
| Dec. 9, 2025 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | S | Common Stock | 15896 | $25.03 | 56,250.0000 | 45,729,000 | 22.03% | 0.03% |
| Dec. 10, 2025 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | M | Common Stock | 9104 | $16.45 | 65,354.0000 | 45,729,000 | 16.18% | 0.02% |
| Dec. 10, 2025 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | S | Common Stock | 9104 | $25.14 | 56,250.0000 | 45,729,000 | 13.93% | 0.02% |
| Nov. 10, 2025 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | S | Common Stock | 12060 | $22.09 | 56,250.0000 | 45,729,000 | 17.65% | 0.03% |
| Oct. 31, 2025 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | F | Common Stock | 6690 | $21.38 | 68,310.0000 | 45,729,000 | 8.92% | 0.01% |
| Nov. 4, 2024 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 46,269,000 | 9999.99% | 0.43% |
| Nov. 1, 2024 | Pacira BioSciences, Inc. | $PCRX | Cross Shawn | Chief Financial Officer | A | Common Stock | 75000 | $0.00 | 75,000.0000 | 46,269,000 | 9999.99% | 0.16% |